Clinical Observation on the Effectiveness of Tongqiao Sanjie Recipe with Ultrasonic Nebulized Nasal Inhalation in Treating OSAHS Caused by Adenoid Hypertrophy in Childre

Phase 1

• Conditions: OSAHS caused by adenoid hypertrophy in children

• Registration Number: ITMCTR2100004542
• Lead Sponsor: Tianshan Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Western medical standards:
1. PSG monitoring meets the standards of the Draft Guidelines for Childhood OSAHS Diagnosis and Treatment (Urumqi) formulated by the Otolaryngology Branch of the Chinese Medical Association in 2007;
2. OSAHS children were born at full term, and their height and weight at birth were within the normal range There are no special circumstances in the feeding history and growth history;
3. The children with OSAHS in the group are between 3 and 12 years old, and have not yet entered puberty, and their living environment is not significantly different;
4. All children are identified as adenoids ( Pharyngeal tonsils) hypertrophy;
5. Mometasone furoate nasal spray was not used for 1 month before treatment.
TCM standards:
Refer to the Thirteenth Five-Year Plan textbooks for higher education in the Chinese medicine industry in the country, and the Chinese Medicine Otorhinolaryngology published by People's Medical Publishing House edited by Ruan Yan. Meet the snoring disease phlegm and blood stasis mutual accumulation standard.

Exclusion Criteria

1. Patients diagnosed by PSG monitoring as central or mixed OSAHS;
2. The child has congenital and genetic diseases and craniofacial deformities;
3. Severe neonatal asphyxia, hypoxic ischemic encephalopathy at birth;
4. A history of chronic diseases such as tuberculosis, viral hepatitis, nephrotic syndrome or major trauma after birth;
5. Children who have had a history of cerebral palsy and seizures after birth;
6. Recurrent history of upper respiratory tract infection;
7. Simple or accompanied by tonsillar hypertrophy or higher or upper respiratory tract mouth, laryngopharyngeal part and other causes of airway stenosis or even collapse;
8. Allergic to research drugs.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
AHI;LSaO2;